The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to ...

Rapamycin is used to prevent graft rejection in transplant recipients based on its ability to suppress T-cell proliferation. The drug blocks the activity of a protein known as mammalian target of ...

A groundbreaking review highlights significant advancements in the understanding and treatment of cerebral vascular ...

Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions ...